Industry Sector

Optical devices — US PTAB Patent Cases

5 decisions indexed

Page 1 of 1 · 5 total

patent terminated or settled · Apr 28, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00901

Apple and Apex Beam Technologies jointly moved to terminate sixteen IPRs after reaching a settlement. The Board granted the motion, treating the settlement agreements as confidential. No claim merits were decided.

patent terminated or settled · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00905

Apple and Apex Beam Technologies settled their disputes, leading to the joint termination of sixteen IPRs covering laser‑beam‑steering patents. The Board granted the motion, citing good cause and public‑policy benefits of settlement.

patent · Dec 7, 2024

BOE Technology Group Co., LTD v.Optronic Sciences LLC

· IPR2024-01132

BOE Technology and Optronic Sciences filed a joint notice confirming that the IPR oral hearing transcript and final written decision will be made fully public, and that specific exhibits will not remain sealed.

patent instituted · Feb 5, 2024

Giesecke+Devrient GmbH et al. v.Lumenco, LLC

· IPR2024-00839

Giesecke+Devrient et al. successfully petitioned to challenge Lumenco's patent on Optically Variable Devices (OVDs) for document security. The PTAB found the grounds of obviousness compelling, leading to institution of the IPR proceedings.

patent null · Feb 5, 2024

Giesecke+Devrient GmbH et al. v.Lumenco, LLC

· IPR2024-00837

Giesecke+Devrient GmbH filed a petition challenging the validity of Lumenco's micro-mirror array patent under 35 U.S.C. §103. The petitioner argues that the claimed technology is obvious, citing combinations of prior art references like Fuhse262 and Jordan. This initial filing sets the stage for a detailed examination of inventive step in optical device design.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →